0 Items
Select Page

Human Papillomavirus

Human papillomaviruses (HPVs) are globally widespread and are tropic for epithelial cells. Different HPVs display a preference for distinct sites of the body, infecting either cutaneous or mucous membranes. Most HPV infections are asymptomatic or give rise to benign warts.

However, a large subset of HPVs, referred to as high-risk genotypes, can cause infectious lesions that may lead to premalignant and malignant cancers of the genital tract. At least thirteen HPVs are recognised as high-risk genotypes that have been associated with malignant disease.

At the Native Antigen Company, we offer a range of monoclonal antibodies recognising Human Papillomavirus (HPV) genotypes for immunoassay research and development. The range includes matched capture-detection antibody pairs for use in sandwich immunoassays and western blotting.

Human Papillomavirus Background

Human papillomaviruses (HPV) are small, non-enveloped, DNA viruses that belong to the family Papillomaviridae.  Over 150 genotypes have been identified to date. which are divided into 5 genera, based on DNA sequencing.

Human papillomaviruses (HPVs) are globally widespread and are tropic for epithelial cells. Different HPVs display a preference for distinct sites of the body, infecting either cutaneous or mucous membranes. Most infections, caused by HPVs, are asymptomatic or cause benign warts. Some HPVs cause latent infection which can be re-activated under certain circumstances, such as stress and immunosuppression (McMurray, HR).

However, a large subset of high-risk HPV genotypes can cause infectious lesions that may lead to premalignant and malignant cancers of the genital tract. At least thirteen HPVs are recognised as high-risk genotypes causing malignant disease. The most common high-risk genotypes are HPV 16 and 18, which are frequently associated with cancer of the cervix (Doorbar, J). Transmission of high-risk HPV genotypes occurs via skin-to-skin contact during sexual activity.

In recent years, a successful vaccine has been developed that protects against four HPV strains 6, 11, 16 and 18. Clinical trials suggest that the vaccine prevents pre-cancer caused by HPV 16 and 18 in 99% of cases in young women (WHO).

References

McMurray HR, Nguyen D, Westbrook TF, McAnce DJ. 2001. Biology of human papillomaviruses. Int J Exp Pathol. 2001 Feb;82(1):15-33. Review.

Doorbar J, Egawa N, Griffin H, Kranjec C, Murakami I. Human papillomavirus molecular biology and disease association. 2015. Rev Med Virol. Mar;25 Suppl 1:2-23.

World health organization: Biologicals, Human Papillomavirus

Human Papillomavirus Antibodies

A range of monoclonal antibodies recognising Human Papillomavirus (HPV) genotypes are available for immunoassay research and development. The range includes matched capture-detection antibody pairs for HPV16 and HPV18. These antibodies are suitable for use in sandwich immunoassays and western blotting.

Questions?

Check out our FAQ section for answers to the most frequently asked questions about our website and company.

Challenges to Effective Yellow Fever Diagnostics

Yellow fever is a haemorrhagic viral disease, transmitted by infected mosquitos in Africa and South America. While an effective vaccine is available, inadequate vaccination of endemic areas has made diagnostics a necessity to controlling ongoing outbreaks. However,...

Five Methods You Can Use to Overcome Zika-Dengue Cross-Reactivity

Cross-reactivity between the Zika and Dengue viruses in serological assays is one of the biggest challenges faced by the epidemiologists, academics and pharmaceutical companies trying to control the Zika epidemic, as it brings the quality and reliability of diagnostic...

Why Zika virus’s cross-reactivity with Dengue might be hampering your research

Given the impact of Zika, it’s no surprise that a global contingent of epidemiologists, academic researchers, and pharmaceutical companies are striving to develop effective disease control measures and treatments. One challenge currently hindering the...

How The Native Antigen Company responds to the WHO list of priority infectious diseases

In 2015, a broad group of public health and science experts gathered in Geneva to discuss emerging infectious diseases that are likely to cause future severe epidemics and public health emergencies. Organised by the World Health Organization (WHO), their aim was to...

Native Antigen release a panel of serotype specific monoclonal antibodies

  There are four distinct serotypes of Dengue Virus circulating around the world, causing Dengue fever infection which is the most important worldwide arboviral disease. There are nearly 400 million cases of Dengue annually, and around 25% present with so called...

Get in Touch

We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these

13 + 1 =

Live Customer Feedback